Women's Health Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Institute of Child Health, London
Infants exposed to antiretroviral therapy in utero have persistantly altered hematology parameters
February 5th, 2006
Infants of HIV-1-positive mothers and who were exposed to antiretroviral therapy in utero were reported to have persistantly altered hematology parameters. In a recent article published in the journal Acta Paediatrica, scientists in England conducted a study "To investigate hematological parameters in infants born to HIV-1-infected mothers and exposed to combination antiretroviral therapy (ART) used to prevent mother-to-child transmission (MTCT). "A 2-y single-center follow-up study performed in 109 infants born to HIV-1-positive mothers. Exclusion criteria for the infants were HIV-1 infection, perinatal death, or insufficient information,"...
Source: Women's Health Law Weekly (2006-02-05)
|
